Oxidative protein damage is associated with elevated serum interleukin-6 levels among older moderately to severely disabled women living in the community

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 63, Issue 2, 2008, Pages 179-183

  Dayhoff Brannigan, Margaret ^a   Ferrucci, Luigi ^b   Sun, Kai ^a   Fried, Linda P ^a   Walston, Jeremy ^a   Varadhan, Ravi ^a   Guralnik, Jack M ^b   Semba, Richard D ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c NONE   (United States)

Author keywords

Inflammation; Interleukin 6; Oxidative stress; Protein carbonyls

Indexed keywords

INTERLEUKIN 6; PROTEIN;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DISABILITY; DISABLED PERSON; DISEASE SEVERITY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; HEALTH SURVEY; INFLAMMATION; METABOLISM; PROTEIN CARBONYLATION; QUESTIONNAIRE; REGRESSION ANALYSIS; WOMEN'S HEALTH;

AGED; AGING; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INFLAMMATION; INTERLEUKIN-6; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEINS; QUESTIONNAIRES; REGRESSION ANALYSIS; WOMEN'S HEALTH;

EID: 42449098960     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/63.2.179     Document Type: Article

References (42)

1. Ferrucci L, Corsi A, Lauretani F, et al. The origins of age-related proinflammatory state. Blood. 2005;105:2294-2299.
2. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-844.
3. Hung J, McQuillan BM, Chapman CML, et al. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol. 2005;25:1268-1273.
4. Ross RR. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-126.
5. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639-646.
6. Payette H, Roubenoff R, Jacques PF, et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J Am Geriatr Soc. 2003;51:1237-1243.
7. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119:e9-e17.
8. Cohen JH, Pieper CF, Harris T, Rao KMK, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol Med Sci. 1997;52A:M201-M208.
9. Ferrucci L, Penninx BWJH, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002;50:1947-1954.
10. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging. Neurology. 2002;59:371-378.
11. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245-270.
12. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512.
13. Janssen-Heininger YMW, Poynter ME, Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic Biol Med. 2000;28:1317-1327.
14. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H. Redox regulation of NF-κB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal. 2005;7:395-403.
15. Karin M, Takahashi T, Kapahi P, et al. Oxidative stress and gene expression: the AP-1 and NF-κB connections. Biofactors. 2001;15:87-89.
16. Stadtman ER, Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev. 1998;30:225-243.
17. Traverso N, Menini S, Maineri EP, et al. Malondialdehyde, a lipoperoxidation-derived aldehyde, can bring about secondary oxidative damage to proteins. J Gerontol Biol Sci Med Sci. 2004;59A:890-895.
18. Chevion M, Berenshtein E, Stadtman ER. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res. 2000;33:S99-S108.
19. Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med. 2002;32:797-803.
20. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329:23-38.
21. Kannan M, Wang L, Kang YJ. Myocardial oxidative stress and toxicity induced by acute ethanol exposure in mice. Exp Biol Med. 2004;229:553-559.
22. Guralnik JM, Fried LP, Simonsick EM, Kasper D, Lafferty ME. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. Bethesda, MD: National Institute on Aging. NIH Publication No. 95-4009, 1995.
23. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med. 2003;9:169-176.
24. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res. 2001;9 (Suppl 4):228S-233S.
25. Stadtman ER. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med. 1990;9:315-325.
26. Berlett BS, Levine RL, Stadtman ER. Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: both modifications mimic effects of adenylylation. Proc Natl Acad Sci U S A. 1998;95:2784-2789.
27. Agarwal S, Sohal RS. Differential oxidative damage to mitochondrial proteins during aging. Mech Ageing Dev. 1995;85:59-63.
28. Grune T, Shringarpure R, Sitte N, Davies K. Age-related changes in protein oxidation and proteolysis in mammalian cells. J Gerontol Biol Sci. 2001;56A:B459-B467.
29. Kasapoglu M, Özben T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp Gerontol. 2001;36:209-220.
30. Mutlu-Türkoǧlu Ü, İlhan E, Öztezcan S, Kuru A, Aykaç-Toker G, Uysal M. Age-related increases in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clin Biochem. 2003;36:397-400.
31. Choi J, Malakowsky CA, Talent JM, Conrad CC, Gracy RW. Identification of oxidized plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun. 2002;293:1566-1570.
32. Miyata T. Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress"). Bull Mem Acad R Med Belg. 2002;157:189-196.
33. Agarwal R. Chronic kidney disease is associated with oxidative stress independent of hypertension. Clin Nephrol. 2004;61:377-383.
34. Domínguez C, Gussinye M, Ruiz E, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care. 1998;21:1736-1742.
35. Martín-Gallán P, Carrascosa A, Gussinyá M, Domínguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med. 2003;34:1563-1574.
36. Rutkowska M, Strzyżewski K, Iskra M, Pioruńska-Stolzmann M, Majewski W. Increased protein carbonyl groups in the serum of men with chronic arterial occlusion and the effect of postoperative treatment. Med Sci Monit. 2005;11:CR79-CR83.
37. Howard C, Ferrucci L, Sun K, et al. Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol. 2007;103:17-20.
38. Maes M, DeVos N, Wauters A, et al. Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease. J Psychiatr Res. 1999;33:397-405.
39. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation. 2005;112:976-983.
40. Honda H, Qureshi AR, Heimburger O, et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006;47:139-148.
41. Targher G, Zenari L, Bertolini L, Muggeo M, Zoppini G. Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. Diabetes Care. 2001;24:956-957.
42. Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and cardiovascular disease (the Health, Aging, and Body Composition Study). Am J Cardiol. 2003;92:522-528.